Delivery Order SPE2DB20D2014-SPE2DB25FC99R
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,724.06, for the supply of Trulicity 1.5 mg/0.5 mL pens on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized across military and federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,628.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 4, 2025. This non-set-aside, firm fixed-price delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. Trulicity is a brand-name diabetes medication commonly used within federal healthcare systems, including military and...
- The Defense Logistics Agency (DLA) awarded a $5,783.00 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill the order from its corporate office location. Trulicity is a diabetes medication...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml) with a ceiling value of $9,279.41. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,121.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 15, 2025. This firm fixed-price delivery order, designated as a non-competitive award under the company's existing indefinite delivery contract with DLA, is scheduled for completion by July 16, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,136.77. This is a firm fixed price delivery order with no set-aside designation, reflecting the competitive nature of the award. The order is scheduled for completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC99RDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,713.49. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made on a competitive basis. Trulicity is a brand-name diabetes medication commonly used in military and veteran healthcare systems, aligning with DLA's responsibility for medical supply procurement across the Department of Defense. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp maintains significant federal procurement relationships and demonstrates capability to fulfill diverse medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/15/25 |